Terms ending in 2030
Every in-force patent on GlaxoSmithKline LLC's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D747,478 | Nasal dilator In force · Medium confidence | GlaxoSmithKline LLC | In force | Medium confidence | |
| US 7,994,185 | Benzene Sulfonamide Thiazole and Oxazole Compounds In force · High confidence | Novartis Pharmaceuticals Corporation | In force | High confidence | |
| US 7,960,552 | Farnesoid X Receptor Agonists In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | |
| US 8,563,717 | Novel Adenine Derivatives In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | |
| US 8,930,207 | Medical Product Dispensing Systems and Methods In force · High confidence | Haleon UK IP Limited | In force | High confidence | |
| US 11,094,406 | Medical Product Dispensing Systems and Methods In force · High confidence | Haleon UK IP Limited | In force | High confidence | |
| US 8,552,187 | Processes and Intermediates for Carbamoylpyridone HIV Integrase Inhibitors In force · High confidence | Viiv Healthcare Company | In force | High confidence | |
| US 8,624,023 | Synthesis of Carbamoylpyridone HIV Integrase Inhibitors and Intermediates In force · High confidence | Shionogi & Co., Ltd. | In force | High confidence | |
| US 10,357,798 | Vapor Sheath for Liquid Dispensing Nozzle In force · Medium confidence | GlaxoSmithKline LLC | In force | Medium confidence | |
| US 8,580,967 | Methyl 3-(BENZYLOXY)-1-(2,2-Dihydroxyethyl)-4-OXO-1,4-Dihydropyridine-2-Carboxylate and Processes for the Preparation Thereof In force · High confidence | Viiv Healthcare Company | In force | High confidence | |
| 4 more term ends in 2030 · Pro | |||||
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
6 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.